The goal of the CFTRc is to find a cure for cystic fibrosis. The CFTRc provides a platform for basic CF research and the development of therapies targeting the basic defect that underlies cystic fibrosis and other protein trafficking diseases. It has been established with the support of the successful CFI VI application - The McGill University Life Sciences Complex Disease to therapy initiative – that paid for renovations and new equipment. It is part of a larger McGill initiative on orphan and neglected diseases.
To reach its goal, the CFTRc will:
- Enhance CF research by offering unique infrastructure, state-of-the-art equipment, and network resources that accelerate breakthroughs in the field.
- Provide a translational research platform for the development of therapies that target the basic defect underlying CF and other protein trafficking diseases.
- Develop a trans-Canada lung tissue procurement network and isolate and distribute cells to researchers across the country